Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$Cassava Sciences (SAVA.US)$ New Article stating that removi...

$Cassava Sciences (SAVA.US)$ New Article stating that removing the amyloid plaque is wrong with all those AD drugs that FDA approved and recently approved but later being rejected

´The amyloid hypothesis has struggled to translate into effective treatments’

This is why Filamin A , repairing the misfolded protein with SAVA  Simufilam has MOA, mechanism of acting  slows decline and improves cognition.  A treatment that actually helps with the brain in repairing it’s functions as opposed to removing amyloid plaque like the other ones which causes brain bleeding, swelling and death.  This novel approach helps treat AD better.
$Cassava Sciences (SAVA.US)$ New Article stating that removing the amyloid plaque is wrong with all those AD drugs that FDA approved and recently approved but l...
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
Translate
Report
13K Views
Comment
Sign in to post a comment
    166Followers
    6Following
    456Visitors
    Follow